69 related articles for article (PubMed ID: 38440808)
1. Detangling the Threads of Hairy Cell Leukemia, Beyond the Morphology and Into the Molecular.
Brazel D; Hermel D; Gandhi P; Saven A
Clin Lymphoma Myeloma Leuk; 2024 May; ():. PubMed ID: 38849281
[TBL] [Abstract][Full Text] [Related]
2. Development of a distributed international patient data registry for hairy cell leukemia.
Andritsos LA; Anghelina M; Neal J; Blachly JS; Mathur P; Lele O; Dearden C; Iyengar S; Cross M; Zent CS; Rogers KA; Epperla N; Lozanski G; Oakes CC; Kraut E; Ruppert AS; Zhao Q; Bhat SA; Forconi F; Banerji V; Handunnetti S; Tam CS; Seymour JF; Else M; Kreitman RJ; Saven A; Call T; Parikh SA; Ravandi F; Johnston JB; Tiacci E; Troussard X; Tallman MS; Dietrich S; Tadmor T; Gozzetti A; Zinzani PL; Robak T; Quest G; Demeter J; Rai K; Fernandez SA; Grever M
Leuk Lymphoma; 2022 Dec; 63(13):3021-3031. PubMed ID: 36070610
[TBL] [Abstract][Full Text] [Related]
3. Two cases of q-Fever in hairy cell leukemia.
Ammatuna E; Iannitto E; Tick LW; Arents NL; Kuijper PH; Nijziel MR
Case Rep Hematol; 2014; 2014():863932. PubMed ID: 25180111
[TBL] [Abstract][Full Text] [Related]
4. Hairy cell leukemia - immunotargets and therapies.
Basheer F; Bloxham DM; Scott MA; Follows GA
Immunotargets Ther; 2014; 3():107-20. PubMed ID: 27471703
[TBL] [Abstract][Full Text] [Related]
5. A case report of hairy cell leukemia presenting concomitantly with sweet syndrome.
Alkayem M; Cheng W
Case Rep Med; 2014; 2014():823286. PubMed ID: 24715920
[TBL] [Abstract][Full Text] [Related]
6. Hairy cell leukemia 2022: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Maître E; Cornet E
Am J Hematol; 2022 Feb; 97(2):226-236. PubMed ID: 34710243
[TBL] [Abstract][Full Text] [Related]
7. Hairy cell leukemia 2018: Update on diagnosis, risk-stratification, and treatment.
Troussard X; Cornet E
Am J Hematol; 2017 Dec; 92(12):1382-1390. PubMed ID: 29110361
[TBL] [Abstract][Full Text] [Related]
8. Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.
Cornet E; Delmer A; Feugier P; Garnache-Ottou F; Ghez D; Leblond V; Levy V; Maloisel F; Re D; Zini JM; Troussard X;
Ann Hematol; 2014 Dec; 93(12):1977-83. PubMed ID: 24994538
[TBL] [Abstract][Full Text] [Related]
9. Updates in hairy cell leukemia (HCL) and variant-type HCL (HCL-V): rationale for targeted treatments with a focus on ibrutinib.
Paillassa J; Safa F; Troussard X
Ther Adv Hematol; 2022; 13():20406207221090886. PubMed ID: 35450208
[TBL] [Abstract][Full Text] [Related]
10. Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
Troussard X; Maître E; Paillassa J
Am J Hematol; 2024 Apr; 99(4):679-696. PubMed ID: 38440808
[TBL] [Abstract][Full Text] [Related]
11. Hairy cell leukemia: 2020 update on diagnosis, risk stratification, and treatment.
Maitre E; Cornet E; Troussard X
Am J Hematol; 2019 Dec; 94(12):1413-1422. PubMed ID: 31591741
[TBL] [Abstract][Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
